Evidence map›Paper›PMID 38656940›Full record

ArticleDiabetes2024

Female Protection Against Diabetic Kidney Disease Is Regulated by Kidney-Specific AMPK Activity.

Hak Joo Lee, Liang Min, Jingli Gao, Shane Matta, Viktor Drel, Afaf Saliba, Ian Tamayo, Richard Montellano, Leila Hejazi, Soumya Maity and 7 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Assays to enhance metabolic phenotyping in the kidney.American journal of physiology. Renal physiology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Hak Joo LeeCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.ORCID 0000-0003-3954-3216
Liang MinCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Jingli GaoCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Shane MattaCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Viktor DrelCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Afaf SalibaCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Ian TamayoCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Richard MontellanoCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Leila HejaziCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Soumya MaityCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Guogang XuCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Brian I GrajedaDepartment of Biological Sciences and Border Biomedical Research Center, University of Texas, El Paso, TX.
Sourav RoyDepartment of Biological Sciences and Border Biomedical Research Center, University of Texas, El Paso, TX.
Kenneth R HallowsUSC/UKRO Kidney Research Center, Division of Nephrology and Hypertension, University of Southern California Keck School of Medicine, Los Angeles, CA.
Goutam Ghosh ChoudhuryCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Balakuntalam S KasinathCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
Kumar SharmaCenter for Precision Medicine, Division of Nephrology, University of Texas Health, San Antonio, TX.
The University of Texas Health Science Center at San Antonio · USUniversity of Southern California · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · 1991 to 2026
$59.1M
Human hypothalamic neuronal epigenomics and risk for obesityR01DK114661 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LEHMAN, DONNA M · 2018 to 2021
$2.6M
NRSA Training Core (TL1)TL1TR002647 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHUN, YONG-HEE PATRICIA, FREI, CHRISTOPHER R. · 2018 to 2022
$1.8M
Illumina NovaSeq 6000 Sequencing SystemS10OD030311 · OD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LAI, ZHAO · 2021 to 2021
$600k
BLRD Research Career Scientist Award ApplicationIK6BX005795 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI GHOSH CHOUDHURY, GOUTAM · 2022 to 2024
–
Mitochondrial-Derived Superoxide in Type 2 Diabetic Kidney DiseaseI01BX003234 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI SHARMA, KUMAR · 2016 to 2019
–
New Insights in Mechanisms of Renal InjuryI01BX001340 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI Kumar Sharma · 2012 to 2026
–
Mechanisms of Renal Cell InjuryI01BX000926 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI GHOSH CHOUDHURY, GOUTAM, SHARMA, KUMAR · 2011 to 2024
–
BLRD VA I01 BX000926BLRD VA I01 BX001340BLRD VA I01 BX003234BLRD VA IK6 BX005795CPRIT RP220662NCATS NIH HHS TL1 TR002647NCI NIH HHS P30 CA054174NIDDK NIH HHS R01 DK114661NIH HHS 1S10 OD030311-01NIH HHS S10 OD030311UTEP 19508430VA Merit Review 2I01 BX000926
6 · The paper itself

Abstract

Reduced kidney AMPK activity is associated with nutrient stress-induced chronic kidney disease (CKD) in male mice. In contrast, female mice resist nutrient stress-induced CKD. The role of kidney AMPK in sex-related organ protection against nutrient stress and metabolite changes was evaluated in diabetic kidney tubule-specific AMPKγ2KO (KTAMPKγ2ΚΟ) male and female mice. In wild-type (WT) males, diabetes increased albuminuria, urinary kidney injury molecule-1, hypertension, kidney p70S6K phosphorylation, and kidney matrix accumulation; these features were not exacerbated with KTAMPKγ2ΚΟ. Whereas WT females had protection against diabetes-induced kidney injury, KTAMPKγ2ΚΟ led to loss of female protection against kidney disease. The hormone 17β-estradiol ameliorated high glucose-induced AMPK inactivation, p70S6K phosphorylation, and matrix protein accumulation in kidney tubule cells. The mechanism for female protection against diabetes-induced kidney injury is likely via an estrogen-AMPK pathway, as inhibition of AMPK led to loss of estrogen protection to glucose-induced mTORC1 activation and matrix production. RNA sequencing and metabolomic analysis identified a decrease in the degradation pathway of phenylalanine and tyrosine resulting in increased urinary phenylalanine and tyrosine levels in females. The metabolite levels correlated with loss of female protection. The findings provide new insights to explain evolutionary advantages to females during states of nutrient challenges. ARTICLE HIGHLIGHTS:

Indexed as

AMP-Activated Protein KinasesDiabetic NephropathiesKidneyAnimalsDiabetes Mellitus, ExperimentalEstradiolFemaleMaleMiceMice, KnockoutPhosphorylationRibosomal Protein S6 Kinases, 70-kDaAMP-Activated Protein KinasesEstradiolRibosomal Protein S6 Kinases, 70-kDa

Identifiers

PMID38656940
PMCPMC11189830
OpenAlexW4395115869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.